ResearcherChinese PLA General HospitalActive in the last 2 years

Bo Yeun Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8989-9387; OpenAlex author ID A5043791066. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study. Last author DOI 10.1002/cai2.123 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Boyu Qin · 1 shared paper, 2024 · strength 0.19
- Paper Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cance… DOI 10.1002/cai2.123 ↗
Jing Zhang · 1 shared paper, 2024 · strength 0.19
- Paper Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cance… DOI 10.1002/cai2.123 ↗
Ke Li · 1 shared paper, 2024 · strength 0.19
- Paper Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cance… DOI 10.1002/cai2.123 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.